TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Novo Nordisk Scandinavia AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,968,847
|
1,793,809
|
1,166,767 |
| Financial expenses |
1,485
|
401
|
86 |
| Earnings before taxes |
77,654
|
71,492
|
51,179 |
| EBITDA |
71,062
|
66,530
|
49,993 |
| Total assets |
385,762
|
487,581
|
447,401 |
| Current assets |
384,010
|
487,323
|
447,033 |
| Current liabilities |
202,504
|
319,806
|
304,670 |
| Equity capital |
140,924
|
127,342
|
99,589 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
123
|
110
|
115 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
36.5%
|
26.1%
|
22.3% |
| Turnover per employee |
16,007
|
16,307
|
10,146 |
| Profit as a percentage of turnover |
3.9%
|
4.0%
|
4.4% |
| Return on assets (ROA) |
20.5%
|
14.7%
|
11.5% |
| Current ratio |
189.6%
|
152.4%
|
146.7% |
| Return on equity (ROE) |
55.1%
|
56.1%
|
51.4% |
| Change turnover |
175,038
|
627,042
|
230,325 |
| Change turnover % |
10%
|
54%
|
25% |
| Chg. No. of employees |
13
|
-5
|
9 |
| Chg. No. of employees % |
12%
|
-4%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.